Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Sales | 1,336 | 1,230 | 1,466 | 1,363 | 1,433 |
| Gross Profit | 1,336 | 1,230 | 1,466 | 1,363 | 1,433 |
| Operating Income | 1,336 | 1,230 | 1,466 | 1,363 | 1,433 |
| Pre-tax Income | 1,336 | 1,230 | 1,466 | 1,363 | 1,433 |
| Net Income Continuous | -3,839 | -3,883 | -5,451 | -4,152 | -7,618 |
| Net Income | $-3,839 | $-3,883 | $-5,451 | $-4,152 | $-7,618 |
| EPS Basic Total Ops | -5.40 | -6.12 | -9.00 | -6.84 | -12.60 |
| EPS Basic Continuous Ops | -5.83 | -6.21 | -8.84 | -6.76 | -12.52 |
| EPS Diluted Total Ops | -5.40 | -6.12 | -9.00 | -6.84 | -12.60 |
| EPS Diluted Continuous Ops | -5.83 | -6.21 | -8.84 | -6.76 | -12.52 |
| EBITDA(a) | $1,336 | $1,230 | $1,466 | $1,363 | $1,433 |